Tecentriq (Atezolizumab 1200mg/20mL) Injection
Tecentriq (Atezolizumab) is a prescription cancer immunotherapy medicine belonging to the class of PD-L1 (Programmed Death-Ligand 1) inhibitors. It is designed to help the body’s immune system recognize and destroy cancer cells more effectively by blocking the PD-L1 pathway, which tumors use to evade immune detection.
Tecentriq 1200mg/20mL Injection is widely used in modern oncology for treating several types of advanced cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), triple-negative breast cancer, hepatocellular carcinoma (liver cancer), and urothelial carcinoma (bladder cancer). It is administered as an intravenous infusion in hospitals under strict medical supervision as part of immunotherapy or combination cancer treatment protocols.
🌍 GlobMedIndia – The Medicine Exporter (Contact & Order Details)
GlobMedIndia – The Medicine Exporter is a trusted international pharmaceutical supplier providing fast, safe, and secure worldwide doorstep delivery of medicines. We specialize in exporting life-saving and critical care medicines, including anti-cancer drugs, targeted therapies, injectables, and specialty pharmaceuticals across global markets. We ensure authentic, high-quality, and temperature-controlled pharmaceutical delivery directly from India to patients, hospitals, and healthcare providers worldwide.
Contact Details;-
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
https://globmedsindia.com
💊 Composition & Content
Each vial of Tecentriq 1200mg/20mL contains:
- Active ingredient: Atezolizumab 1200 mg
- Formulation: Sterile solution for intravenous infusion
- Volume: 20 mL single-dose vial
- Class: Monoclonal antibody (IgG1) targeting PD-L1 protein
🧾 How to Use & Dosage
- Administered only via intravenous (IV) infusion in a hospital setting
- Standard dose: 1200 mg every 3 weeks (adjusted based on cancer type)
- First infusion typically over 60 minutes, may be reduced if tolerated
- Must be given under supervision of oncology specialists
- Often used alone or in combination with chemotherapy or targeted therapy
⚠️ This medicine must never be self-administered.
🎯 Uses of Tecentriq Injection
Tecentriq is indicated for:
- Non-small cell lung cancer (NSCLC)
- Small cell lung cancer (SCLC)
- Triple-negative breast cancer (TNBC)
- Hepatocellular carcinoma (liver cancer)
- Urothelial carcinoma (bladder cancer)
- Other advanced or metastatic cancers as prescribed by oncologists
⚕️ Treatment Advantages
- Strengthens immune system’s ability to attack cancer cells
- Slows tumor growth and disease progression
- Improves survival outcomes in multiple cancer types
- Can be used in combination with chemotherapy or targeted therapies
- Advanced immunotherapy with precision mechanism
🏭 Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vial
- Must be handled under strict hospital cold-chain conditions
🇮🇳 Alternative Indian Brands / Biosimilars
Currently:
- There are no widely approved Indian biosimilar versions of Atezolizumab (Tecentriq) in routine clinical use
- The original innovator product is manufactured by Roche (Tecentriq)
- Biosimilar development is still in research and global pipeline stages
Tecentriq Atezolizumab Injection
Buy Tecentriq Atezolizumab 1200mg injection online, Atezolizumab immunotherapy cancer drug USA export India, PD-L1 inhibitor injection supplier GlobMedIndia, Tecentriq injection California New York Houston Chicago delivery, cancer immunotherapy medicine USA India exporter, Atezolizumab 1200mg 20ml vial international shipping, buy cancer immunotherapy drug USA pharmacy supply, best lung cancer immunotherapy injection, Tecentriq injection USA oncology treatment import, trusted Indian pharma exporter GlobMedIndia oncology medicines
🌎 Worldwide Delivery – United States Coverage
Fast and secure export delivery available to:
California, Washington, Chicago, Los Angeles, Houston, Phoenix, Austin, Columbus, Philadelphia, San Antonio, San Diego, Dallas, Jacksonville and across the United States of America.
